Nutex Health CEO reports 75,747-share restructuring move
Nutex Health Inc. director and CEO Thomas T. Vo reported an "other" Form 4 transaction involving 75,747 shares of common stock held indirectly through Micro Hospital Holdings LLC.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Nutex Health Inc. director and CEO Thomas T. Vo reported an "other" Form 4 transaction involving 75,747 shares of common stock held indirectly through Micro Hospital Holdings LLC. The shares were issued in a private transaction to satisfy one-time obligations tied to two under-construction hospitals.
Following this restructuring-related issuance, Micro Hospital Holdings LLC is shown as holding 2,103,014 Nutex Health common shares indirectly for Vo, who owns and controls the LLC.
Insider Trade Summary
Other: 75,747 shares
Other
1 txn
Insider
Vo Thomas T.
Role
Chief Executive Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Other | Common Stock | 75,747 | $0.00 | $0.00 |
Holdings After Transaction:
Common Stock — 2,103,014 shares (Indirect, By Micro Hospital Holdings LLC)
Footnotes (2)
- F1. Represents the issuance in private transaction of 62,994 and 12,753 shares of common stock, respectively, with respect to the Issuer's one-time obligations related to the reporting person's pro-rata share of two under construction hospitals previously transferred to Nutex Health Holdco LLC pursuant to the Agreement and Plan of Merger dated November 23, 2021, as described in the Issuer's definitive proxy statement on Schedule 14A filed with the Securities and Exchange Commission (SEC) on February 14, 2022, as supplemented, and the Form 10-K filed with the SEC on March 5, 2026.
- F2. Thomas T. Vo, the Chairman and CEO of the registrant, owns and controls Micro Hospital Holding LLC, the direct owner of the securities of the registrant reported herein.
Key Figures
Restructuring shares: 75,747 shares
Private issuance tranche 1: 62,994 shares
Private issuance tranche 2: 12,753 shares
+1 more
4 metrics
Restructuring shares
75,747 shares
Other acquisition or disposition on Form 4
Private issuance tranche 1
62,994 shares
Part of one-time obligation settlement
Private issuance tranche 2
12,753 shares
Part of one-time obligation settlement
Shares held after transaction
2,103,014 shares
Indirectly via Micro Hospital Holdings LLC following transaction
Key Terms
Form 4, indirect ownership, Agreement and Plan of Merger, definitive proxy statement, +1 more
5 terms
Form 4 regulatory
"INSIDER FILING DATA (Form 4):"
Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.
indirect ownership financial
"direct_or_indirect": "I","nature_of_ownership": "By Micro Hospital Holdings LLC""
Agreement and Plan of Merger regulatory
"previously transferred to Nutex Health Holdco LLC pursuant to the Agreement and Plan of Merger dated November 23, 2021"
An Agreement and Plan of Merger is a formal document where two companies agree to combine into one, outlining how the process will happen. It’s like a step-by-step plan for merging, and it matters because it shows both sides have agreed on the details before the official transition takes place.
definitive proxy statement regulatory
"described in the Issuer's definitive proxy statement on Schedule 14A filed"
A Definitive Proxy Statement is a detailed document that a company sends to its shareholders before a big meeting, like voting on important decisions. It explains what's being voted on and gives important information so shareholders can make informed choices. It matters because it helps shareholders understand and participate in key company decisions.
Schedule 14A regulatory
"definitive proxy statement on Schedule 14A filed with the Securities and Exchange Commission"
Schedule 14A is a document that companies file with regulators to share important information with shareholders before a big vote, like approving a merger or election of directors. It matters because it helps investors understand what’s happening so they can make informed decisions about the company’s future.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Nutex Health (NUTX) report for Thomas T. Vo?
Thomas T. Vo reported an "other" Form 4 transaction for 75,747 Nutex Health common shares. These shares were issued in a private transaction to Micro Hospital Holdings LLC to satisfy one-time obligations related to two under-construction hospitals.
Was the Nutex Health (NUTX) Form 4 transaction a market buy or sell?
The Form 4 uses transaction code J, labeled as "Other acquisition or disposition," not a standard market buy or sell. It describes a restructuring-type private issuance to satisfy specific one-time obligations linked to two under-construction hospitals, rather than open-market trading.
How is the Nutex Health (NUTX) Form 4 transaction linked to prior merger agreements?
The footnotes tie this issuance to obligations from an Agreement and Plan of Merger dated November 23, 2021. Those obligations relate to Thomas T. Vo’s pro-rata share of two under-construction hospitals previously transferred to Nutex Health Holdco LLC under that merger structure.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates